Basics Terns Pharmaceuticals, Inc. IPO Date: February 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $631.83M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 4.15% Avg Daily Range (30 D): $0.23 | 3.62% Avg Daily Range (90 D): $0.17 | 3.74% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): 1M Avg Daily Volume (90 D): .85M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 102 Avg Trade Size (Sh.) (90 D): 108 Institutional Trades Total Inst.Trades: 517 Avg Inst. Trade: $1.77M Avg Inst. Trade (30 D): $1.11M Avg Inst. Trade (90 D): $1.13M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.65M Avg Closing Trade (30 D): $.8M Avg Closing Trade (90 D): $.86M Avg Closing Volume: 204.62K     News Sep 18, 2024 @ 2:07 PM This Small-Cap Stock Has a Promising GLP-1 Drug Wh... Source: David Jagielski Sep 15, 2024 @ 11:21 AM Missed Out on Viking Therapeutics? Buy This Weight... Source: Alex Carchidi Sep 15, 2024 @ 10:09 AM Should You Invest in This Under-the-Radar Weight L... Source: Prosper Junior Bakiny Sep 14, 2024 @ 2:12 PM 1 New Weight Loss Drug Stock to Buy Now With $1,00... Source: Alex Carchidi Sep 11, 2024 @ 2:50 AM Terns Announces Pricing of Upsized $150.15 Million... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.03 $-.26 $-.26 Diluted EPS $-1.03 $-.26 $-.26 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -91.75M $ -24.09M $ -23.91M Operating Income / Loss $ -105.7M $ -27.38M $ -27.43M Cost of Revenue $ $ $ Net Cash Flow $ 54.47M $ 6.94M $ -22.42M PE Ratio